The Incidence and Nature of Adverse Events During Pediatric Sedation for MRI/CT in One Korean University Hospital: Retrospective Study

Brief Summary

Sedation and anesthesia for diagnostic imaging represents a rapidly growing field of practice, especially in children. Propofol is the most common sedative drug administered for MRI/CT. However, this drug is associated with adverse events, including pulmonary complications, and there has been no report on these complications in Korea. The investigators reviewed 3739 charts of pediatric patients sedated for MRI/CT between January and November 2012. In this study, the investigators will report the nature and frequency of adverse events associated with sedation for MRI/CT between January and November 2012.

Intervention / Treatment

  • pediatric sedation (propofol, ketamine, etc) (DRUG)
    Presedation assessment was performed by hospitalists and pediatric sedation was performed by protocol in the sedation unit. Data on demographics, primary illness, ASA, snoring history, URI symptom, medications used, procedure and recovery times, medication doses, outcomes of anesthesia, airway interventions and adverse events were collected retrospectively.

Condition or Disease

  • Children Requiring Sedation for MRI/CT

Phase

Study Design

Study type: OBSERVATIONAL
Status: Unknown status
Study results: No Results Available
Age: up to 18 Years   (Child, Adult)
Enrollment: 3739 (ESTIMATED)
Funded by: Other
Time Perspective: Retrospective

Masking

Clinical Trial Dates

Start date: Nov 01, 2012
Primary Completion: Jul 01, 2013 ESTIMATED
Completion Date: Oct 01, 2013 ESTIMATED
Study First Posted: May 16, 2013 ESTIMATED
Results First Posted: Aug 31, 2020
Last Updated: May 13, 2013

Sponsors / Collaborators

Lead Sponsor: Yonsei University
Lead sponsor is responsible party
Responsible Party: N/A

Participant Groups

  • Children requiring sedation for MRI/CT

Eligibility Criteria

Sex: All
Maximum Age: 18
Age Groups: Child / Adult
Healthy Volunteers: Yes

Inclusion Criteria:

* Requiring sedation for MRI/CT, aged 0- 18 years

Exclusion Criteria:

* None

Primary Outcomes
  • The investigators will review all adverse events that are associated with pediatric sedation for MRI/CT

More Details

NCT Number: NCT01855581
Other IDs: 4-2012-0923
Study URL: https://clinicaltrials.gov/study/NCT01855581
Last updated: Sep 29, 2023